Therapeutic strategy in the transplanted patient DOI Creative Commons
María José Núñez-Orantos, Agustín Julián-Jiménez, Francisco Javier Candel

и другие.

Revista Española de Quimioterapia, Год журнала: 2023, Номер 36(Suppl1), С. 18 - 21

Опубликована: Ноя. 24, 2023

The SARS-CoV-2 infection prognosis has dramatically changed as a result of population vaccination and the surge omicron. However, there are still specific populations at risk progression to severe diseases that require hospitalization or even death. kidney transplant is one them. Consequently, when compatible symptoms appear, an early diagnosis should be sought in order start antiviral treatment soon possible avoid clinical deterioration patient. Antivirals have shown, patients, decrease rate death, especially with their administration.

Язык: Английский

International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates—2024 DOI
Yael Peled,

Anique Ducharme,

M. Kittleson

и другие.

The Journal of Heart and Lung Transplantation, Год журнала: 2024, Номер 43(10), С. 1529 - 1628.e54

Опубликована: Авг. 8, 2024

Язык: Английский

Процитировано

29

EASL Clinical Practice Guidelines on liver transplantation DOI
Eléonora De Martin, Thomas Berg, Didier Samuel

и другие.

Journal of Hepatology, Год журнала: 2024, Номер 81(6), С. 1040 - 1086

Опубликована: Окт. 31, 2024

Язык: Английский

Процитировано

24

Lung Transplantation DOI
Jason D. Christie, Dirk Van Raemdonck, Andrew J. Fisher

и другие.

New England Journal of Medicine, Год журнала: 2024, Номер 391(19), С. 1822 - 1836

Опубликована: Ноя. 13, 2024

Lung transplantation has evolved from an experimental to a standard treatment. The authors review recent developments and future opportunities in the delivery of this potentially life-transforming therapy.

Язык: Английский

Процитировано

14

S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV) DOI
Thomas Berg, Niklas Aehling, Tony Bruns

и другие.

Zeitschrift für Gastroenterologie, Год журнала: 2024, Номер 62(09), С. 1397 - 1573

Опубликована: Сен. 1, 2024

Процитировано

7

Donor-derived infections in solid organ transplant recipients DOI
Maddalena Peghin, Paolo Grossi

Current Opinion in Organ Transplantation, Год журнала: 2023, Номер 28(5), С. 384 - 390

Опубликована: Авг. 8, 2023

The potential for transmission of donor-derived infections (DDIs) is impossible to eliminate, but a thoughtful and systematic approach donor evaluation can mitigate the risk. Prevention key issue clinicians must maintain high index suspicion remain vigilant in staying up date on emerging infections. COVID-19 Monkeypox have represented new challenge infectious disease screening recommendations been evolving, as knowledge field has grown. Additional considerations pretransplant deceased include testing neglected endemic diseases such strongyloidiasis HTLV 1/2. Molecular diagnostic tests improved awareness pathogenicity mollicutes fungi setting DDIs. aim this review provide an update most recent literature DDI with special focus these hot topics.

Язык: Английский

Процитировано

10

Child Organ Offer Process (cOOPS): Understanding Infectious Risk Assessment and Mitigation Strategies DOI
Taekhee Lee, Katya Prakash, Hannah Bahakel

и другие.

Pediatric Transplantation, Год журнала: 2025, Номер 29(4)

Опубликована: Май 7, 2025

ABSTRACT Introduction Pediatric Infectious Disease (PID) clinicians involved in solid organ transplantation often assess infection risk and mitigation strategies for donor offers. While some guidance is available, real‐life practice patterns have not been previously described. Methods We surveyed PID about acceptance associated posttransplantation interventions using 12 fictitious pediatric case scenarios through 3 PID‐specific listservs. Descriptive statistics were employed. Results 48 (71.6%) of 67 ID respondents offer assessment. Agreement was strong (> 80%) to accept (syphilis, severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2], MRSA, E. coli , TB [liver], rhino/enterovirus) or decline (undifferentiated encephalitis, [lung]) organs from these cases, while there less agreement cases with coccidioidomycosis, Chagas disease, multi‐drug‐resistant Acinetobacter baumannii influenza. Less present posttransplant monitoring antimicrobial administration. Practice varied testing treatment donors SARS‐CoV‐2 positive test, MRSA bacteremia, disease. Conclusions For many scenarios, high; however, improved education based on currently available recommendations may enhance decision‐making. The variability management highlights educational research opportunities optimize limit the impact donor‐derived infections recipients.

Язык: Английский

Процитировано

0

Comparison of Short-Term Outcomes in Kidney Transplant Recipients from SARS-CoV-2–Infected versus Noninfected Deceased Donors DOI Open Access
Junji Yamauchi, Ambreen Azhar, Isaac E. Hall

и другие.

Clinical Journal of the American Society of Nephrology, Год журнала: 2023, Номер 18(11), С. 1466 - 1475

Опубликована: Авг. 14, 2023

Acceptable post-transplant outcomes were reported in kidney transplant recipients from donors with coronavirus disease 2019 (COVID-19); however, there are no comparative studies well-matched controls.

Язык: Английский

Процитировано

6

“They paged me what?”: A transplant infectious disease guide to donor calls DOI Open Access
Chelsea A. Gorsline,

Robert Sean Tyler,

Rachel Sigler

и другие.

Transplant Infectious Disease, Год журнала: 2023, Номер 25(6)

Опубликована: Ноя. 8, 2023

Donor-derived infections in solid organ transplantation can be prevented by risk stratification of donors based on available information, and inquiries surrounding possible or diagnosed infection are common questions posed to transplant infectious disease subspecialists. This article outlines the five key steps addressing a donor call from team systematic approach, focusing recipient-specific factors, transmissibility treatment infections, likelihood patient's future offers mortality remaining waitlist. These principles then applied cases, which we review takeaway points supporting literature. cases used as resource for teaching with trainees.

Язык: Английский

Процитировано

6

Donor‐derived infections in the United States: Opportunities to learn from the Disease Transmission Advisory Committee's experience DOI
Lara Danziger‐Isakov, Ricardo M. La Hoz, Cameron R. Wolfe

и другие.

Transplant Infectious Disease, Год журнала: 2024, Номер unknown

Опубликована: Июнь 17, 2024

Abstract The Disease Transmission Advisory Committee (DTAC) of the Organ Procurement and Transplantation Network focuses on issues related to transmission disease through organ transplantation. Providing a review potential cases transmission, translating aggregate data into actionable education guidance for transplant community, providing input policy development, DTAC aims improve safety transplantation reduction in donor‐derived events. Through its nearly 20‐year history, has provided education, guidance, policy, addressed numerous emerging infections, continuously focused community's understanding risk assessment transmission. By updating mission both decrease safely expand donor pool with additional use organs previously not considered due concerns, Committee's role will remain critical.

Язык: Английский

Процитировано

2

Minimizing risk while maximizing opportunity: The infectious disease organ offer process survey DOI
Katya Prakash, Kapil Saharia, Andrew H. Karaba

и другие.

Transplant Infectious Disease, Год журнала: 2024, Номер 26(5)

Опубликована: Июль 22, 2024

The purpose of this study was to understand how transplant infectious disease (TID) physicians assess a potential donor with known or suspected infection and describe posttransplant management.

Язык: Английский

Процитировано

2